Dr. Richard I Fisher M.D.
Hematologist-Oncologist | Hematology & Oncology
601 Elmwood Ave # 704 Rochester NY, 14642About
Dr. Richard Fisher is a hematologist oncologist practicing in Rochester, NY. Dr. Fisher specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Harvard Med Sch, Boston Ma 1970
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993.
- Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin's lymphoma.
- Phase II trial of menogaril in non-Hodgkin's lymphomas: a Southwest Oncology Group trial.
- Long-term survival update for high-dose recombinant interleukin-2 in patients with renal cell carcinoma.
- Diffuse large-cell lymphoma.
- Characterization of the lymphocyte surface receptors for Con A and PHA.
- Autologous bone marrow transplantation for aggressive non-Hodgkin's lymphoma: lessons learned and challenges remaining.
- Infusional CHOP chemotherapy (CVAD) with or without chemosensitizers offers no advantage over standard CHOP therapy in the treatment of lymphoma: a Southwest Oncology Group Study.
- Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma.
- Current therapeutic paradigm for the treatment of non-Hodgkin's lymphoma.
- The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features.
- Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: results of two phase II cytokine working group trials.
- Treating Hodgkin's disease with bispecific antibodies: Both patients and antibody are limiting.
- The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin's lymphoma: an evidence-based review.
- Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's disease.
Dr. Richard I Fisher M.D.'s Practice location
Dr. Richard I Fisher M.D.'s reviews
Write ReviewPatient Experience with Dr. Fisher
Recommended Articles
- 'Sophie the Brave' Fights Childhood T-Cell Lymphoma
The story of 2-year-old Sophie Skiles and her arduous battle with T-cell lymphoma pulls at one’s heartstrings while also causing one to marvel at the faith of her Mom, Shelby.The public first learned of Sophie when a newscast about her was posted online October 20, 2017. (KLTB/abc) It soon made it...
- 7-year-old with Lymphoma Joins and Inspires Lacrosse Team
Sports have a way of bringing together families, strangers, and communities. All over the world people celebrate games and competitions and use them to lift people’s spirits and strengthen bonds. Sporting events are also frequently used to raise awareness about important causes, whether locally or...
- What Specialists Treat Multiple Myeloma?
If you suffer from multiple myeloma, which a rare form of blood cancer, one of the most crucial decisions you will have to make is choosing a doctor who specializes in multiple myeloma. A hematologist-oncologist is the specialist you need who will manage your cancer throughout the cycle of...
- Potential Causes of Leukopenia
IntroductionA decrease in the number of white blood cells (WBCs) is referred to as leukopenia. There are several causes for leukopenia. It may be due to certain drugs, cancer, radiation and chemotherapy for cancer, stem cell transplant, surgery, steroids, or autoimmune disorders. The immune system...
- Bringing Chronic Lymphocytic Leukemia Patients and Their Doctors Together via Survey
While patients may entirely admire and respect their doctors, sometimes they simply do not agree with the course of action they are proposing. While this may not be a big deal for a visit about a cold or something minimal, it can be life-altering for those with chronic conditions. That is why a...
- Roles of the National Coalition for Cancer Survivorship
The National Coalition for Cancer Survivorship (NCCS) is a nonprofit, cancer advocacy organization that is located just outside of Washington D.C. To date, it is the oldest survivor-led cancer advocacy organization in the United States.The NCCS represents millions of Americans who share a common...
Nearby Providers
- Dr. William Muuse MD601 ELMWOOD AVE ROCHESTER NY 14642
- Dr. Peter Kouides M.D.1425 Portland Ave Rochester NY 14621
- Dr. Zachary Kramer M.D.1425 Portland Ave Rochester NY 14621
- Dr. John M Bennett M.D.601 Elmwood Avenue Rochester NY 14642
- Dr. Maria Sbenghe M.D.1425 Portland Ave Rochester NY 14621
- Dr. Omar Salah Aljitawi M.D.601 ELMWOOD AVE ROCHESTER NY 14642